Population
Families with facioscapulohumeral disease (140 meioses analyzed)
Design
Other
Authors
Loading...
Supports FSHD linkage testing with pH30; leaves open presymptomatic or prenatal use pending validation.
The identification of a closely linked DNA marker (pH30) for facioscapulohumeral disease enables potential clinical application in presymptomatic and prenatal diagnosis.
Upadhyaya et al. (1991) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: